Genesis Healthcare, Inc. (NYSE:GEN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 22, 2016, Robert A. “Mike” Reitz, Executive Vice President and Chief Operating Officer of Genesis Healthcare, Inc. (the “Company”), announced his retirement effective as of January 1, 2017. From now until January 1, 2017, Mr. Reitz will remain in his current position. Beginning January 1, 2017, Mr. Reitz will support the Company on a limited project basis focused on the leadership transition and other strategic initiatives such as relationship development with acute care systems and performance improvement projects.
On November 22, 2016, the Company announced the appointment of Paul D. Bach as Chief Operating Officer – Genesis HealthCare effective as of January 1, 2017. Mr. Bach, age 58, has served the Company as the Executive Vice President of the Mid-Atlantic/Southeast Division since 2009. From 1997 to 2009, Mr. Bach served the Company as the Senior Vice President of the Capital Region. From 1984 to 1997, Mr. Bach served the Company in various roles, including Regional Vice President, Regional Director and Nursing Home Administrator.
On November 18, 2016, Joshua Hausman notified the Company’s Board of Directors (the “Board”) of his decision to resign from the Board effective as of November 18, 2016. Mr. Hausman’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Company and the Board wish to express their gratitude to Mr. Hausman for his years of service to the Company.
